Clinical Trial: Phase II Clinical Study on the Safety and Efficacy of Chemotherapy Regimens Based on Paclitaxel Polymer Micelles for Injection in the Treatment of Metastatic Pancreatic Cancer as Second-Line and Subsequent Therapy (China)

China, Sept. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase II Clinical Study on the Safety and Efficacy of Chemotherapy Regimens Based on Paclitaxel Polymer Micelles for Injection in the Treatment of Metastatic Pancreatic Cancer as Second-Line and Subsequent Therapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131381

Registration Time: 2026/09/01

Type: Interventional study

Primary Sponsor: Hangzhou First People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335014

Published by HT Digital Content Services with permission from Health Daily Digest....